Product Information
FEIRZA 1.5 MG-30 MCG TABLET is a generic product labeled by Xiromed LLC, priced at $0.1382 per EA under NDC 70700030985. Its NADAC has been published 54 times since Aug 13, 2025.
FDA first approved this application on Feb 20, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
FEIRZA 1.5 MG-30 MCG TABLET
Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1.5 mg/30 mcg and Ferrous Fumarate Tablets, 75 mgManufacturer
Xiromed LLCNDC
70700030985
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA202741FDA Approved
2/20/2015
TE Code
AB
On Market Since
1/29/2025
Price Statistics
The NADAC for FEIRZA 1.5 MG-30 MCG TABLET has been published 54 times since Aug 13, 2025, and over the history we have for it it has declined 6.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1382 per EA |
|---|---|
| All-time high | $0.1575 (Nov 12, 2025) |
| All-time low | $0.1303 (Feb 18, 2026) |
| 52-week high | $0.1575 |
| 52-week low | $0.1303 |
| Median price | $0.1443 |
| Average price | $0.1446 |
| Largest weekly change | -5.5% (Jan 21, 2026) |
| Weeks tracked | 54 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1.5 mg/30 mcg and Ferrous Fumarate Tablets, 75 mg market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FEIRZA 1.5 MG-30 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEIRZA 1.5 MG-30 MCG TABLET, manufactured by Xiromed LLC, is $0.1382 per EA (NDC 70700030985), effective Aug 19, 2026.
How has the price of FEIRZA 1.5 MG-30 MCG TABLET changed over time?
Over the history we have for it, the NADAC for FEIRZA 1.5 MG-30 MCG TABLET has declined 6.9%. It has been tracked across 54 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for FEIRZA 1.5 MG-30 MCG TABLET?
Since Aug 13, 2025, the NADAC for FEIRZA 1.5 MG-30 MCG TABLET has ranged from a low of $0.1303 (Feb 18, 2026) to a high of $0.1575 (Nov 12, 2025), with a median of $0.1443 per EA.
Are there cheaper alternatives to FEIRZA 1.5 MG-30 MCG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of FEIRZA 1.5 MG-30 MCG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FEIRZA 1.5 MG-30 MCG TABLET?
FEIRZA 1.5 MG-30 MCG TABLET (NDC 70700030985) is labeled by Xiromed LLC, and CMS classifies it as a generic product.